UAB Researchers Determine Optimal Immunosuppression Regimen for Pig-to-Human Kidney Transplants, Study Shows
India, March 9 -- Currently used Food and Drug Administration-approved transplant drugs - with the addition of an also already FDA-approved complement inhibitor - are the optimal immunosuppression regimen for pig-to-human kidney transplants, according to a landmark discovery by University of Alabama at Birmingham investigators. The peer-reviewed research is published today in the Journal of Clinical Investigation.
"These findings establish the ideal immunosuppression regimen for pig-to-human kidney xenotransplantation, and it is a regimen that is already FDA-approved and that we routinely use for human-to-human allotransplantation," said Jayme Locke, professor of surgery in UAB's Marnix E. Heersink School of Medicine and lead author of t...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.